Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KOSDAQ/145020 stock hub

KOSDAQ/145020 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/145020is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.1T
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/145020
In the news

Latest news · KOSDAQ/145020

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.8
P25 9.8P50 17.1P75 31.9
Trailing P/E22.7
P25 12P50 23.1P75 39.5
ROE16.1
P25 -17.1P50 0.7P75 8.5
ROIC31.2
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/145020 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
230
Groups with data
11
Currency
KRW
Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
594
Enterprise value
KRW 2.7T
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Biotechnology
Isin
KR7145020004
Last refreshed
2026-05-10
Market cap
KRW 3.1T
Price
KRW 291,500
Price currency
KRW
Rev Per Employee
715,673,372.98x
Sector
Healthcare
Sic
2834
Symbol
kosdaq/145020
Website
https://www.hugel.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
4.47%
EV Earnings
18.95x
EV/EBIT
13.29x
EV/EBITDA
12.1x
EV/FCF
19.53x
EV/Sales
6.28x
FCF yield
4.34%
Forward P/E
23.81x
P/B ratio
3.21x
P/E ratio
22.74x
P/S ratio
7.41x
PE Ratio10 Y
29.61x
PE Ratio3 Y
22.1x
PE Ratio5 Y
26.32x
PEG ratio
0.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
47.17%
EBITDA Margin
51.82%
FCF margin
32.15%
Gross margin
78.45%
Gross Profit
KRW 333.5B
Gross Profit Growth
16.13%
Gross Profit Growth Q
27.01%
Gross Profit Growth3 Y
15.07%
Gross Profit Growth5 Y
17.52%
Net Income
KRW 140.9B
Net Income Growth
3.72%
Net Income Growth Q
-3.5%
Net Income Growth Quarters
1%
Net Income Growth Years
3%
Net Income Growth3 Y
34.94%
Net Income Growth5 Y
27.39%
Pretax Margin
46.28%
Profit Margin
33.14%
Profit Per Employee
KRW 237.2M
Profitable Years
7
ROA
12.43
Roa5y
8.64
ROCE
20.38
ROE
16.14
Roe5y
12.14
ROIC
31.18
Roic5y
26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr10y
10.65%
Cagr1y
-18.81%
Cagr3y
37.46%
Cagr5y
9.83%
EPS Growth
6.94
EPS Growth Q
3.4
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
39.31
EPS Growth5 Y
30.84
FCF Growth
-0.02%
FCF Growth Q
36.7%
FCF Growth3 Y
41.93%
FCF Growth5 Y
18.98%
OCF Growth
0.68%
OCF Growth Q
39.34%
OCF Growth10 Y
22.47%
OCF Growth3 Y
23.01%
OCF Growth5 Y
15.09%
Revenue Growth
13.96x
Revenue Growth Q
21.3x
Revenue Growth Quarters
11x
Revenue Growth Years
6x
Revenue Growth3 Y
14.71x
Revenue Growth5 Y
15.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
KRW 0.42
Assets
KRW 1.1T
Cash
KRW 538.8B
Current Assets
KRW 679.4B
Current Liabilities
KRW 93B
Debt
KRW 29.1B
Debt EBITDA
KRW 0.13
Debt Equity
KRW 0.03
Debt FCF
KRW 0.21
Equity
KRW 980.2B
Interest Coverage
177.5
Liabilities
KRW 96.7B
Long Term Assets
KRW 397.5B
Long Term Liabilities
KRW 3.6B
Net Cash
KRW 509.6B
Net Cash By Market Cap
KRW 16.19
Net Cash Growth
32.08%
Net Debt EBITDA
KRW -2.31
Net Debt Equity
KRW -0.52
Net Debt FCF
KRW -3.73
Tangible Book Value
KRW 839.6B
Tangible Book Value Per Share
KRW 77,729
WACC
7.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
7.3
Inventory Turnover
1.86
Net Working Capital
KRW 75.9B
Quick ratio
6.65
Working Capital
KRW 586.3B
Working Capital Turnover
KRW 0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
3.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
175%
1Y total return
-18.8%
200-day SMA
270,687.5
3Y total return
159.8%
50-day SMA
256,370
50-day SMA vs 200-day SMA
50under200
5Y total return
59.81%
All Time High
392,000
All Time High Change
-25.64%
All Time High Date
2025-07-01
All Time Low
55,499.4
All Time Low Change
425.23%
All Time Low Date
2015-12-28
ATR
15,270
Beta
0.54
Beta1y
1.01
Beta2y
0.68
Ch YTD
26.46
High
298,500
High52
392,000
High52 Date
2025-07-01
High52ch
-25.64%
Low
256,000
Low52
208,500
Low52 Date
2025-11-07
Low52ch
39.81%
Ma50ch
13.7%
Price vs 200-day SMA
7.69%
RSI
65.21
RSI Monthly
54.76
RSI Weekly
57.61
Sharpe ratio
-0.16x
Sortino ratio
-0.13
Total Return
3.12%
Tr YTD
26.46
Tr1m
21.21%
Tr1w
11.47%
Tr3m
19.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
KRW 200.5B
Operating Income Growth
20.64
Operating Income Growth Q
24.45
Operating Income Growth3 Y
25.53
Operating Income Growth5 Y
20.77
Operating margin
47.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
5,441,841%
Net Borrowing
-2,442,394,140
Shares Insiders
0.04%
Shares Institutions
16.66%
Shares Out
10,801,292
Shares Qo Q
-6.44%
Shares Yo Y
-3.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
KRW 129.2B
Average Volume
55,079.5x
Bv Per Share
87,976.4
CAPEX
KRW -13.4B
Ch10y
175
Ch1m
21.21
Ch1w
11.47
Ch1y
-18.8
Ch3m
19.71
Ch3y
159.8
Ch5y
59.81
Ch6m
36.22
Change
12.33%
Change From Open
8.57
Close
259,500
Days Gap
3.47
Depreciation Amortization
19,746,066,000
Dollar Volume
72,310,364,500
Earnings Date
2026-05-07
EBIT
KRW 200.5B
EBITDA
KRW 220.3B
EPS
KRW 12,820
F Score
6
FCF
KRW 136.7B
FCF EV Yield
5.12x
FCF Per Share
KRW 12,653
Financing CF
-21,673,257,950
Fiscal Year End
December
Founded
2,001
Goodwill
78,111,889,000
Graham Number
159301.9929
Graham Upside
-45.35
Income Tax
KRW 49.8B
Investing CF
-48,744,554,190
Is Primary Listing
1
Last Earnings Date
2026-05-07
Last Report Date
2025-12-31
Last Split Date
2020-07-08
Last Split Type
Forward
Lynch Fair Value
KRW 320,504
Lynch Upside
9.95
Ma150
251,116.7
Ma150ch
16.08%
Ma20
262,425
Ma20ch
11.08%
Net CF
79,559,130,950
Next Earnings Date
2026-08-06
Open
268,500
P FCF Ratio
23.04
P OCF Ratio
20.98
Position In Range
83.53
Ppne
146,805,693,750
Price Date
2026-05-08
Price EBITDA
KRW 14.29
Ptbv Ratio
3.75
Relative Volume
5.34x
Revenue
425,109,983,550x
SBC By Revenue
1.75x
Share Based Comp
7,421,741,000
Tax By Revenue
11.71x
Tax Rate
25.3%
Tr6m
36.22%
Volume
248,063
Z Score
23.58
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/145020 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/145020 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-18.8%
S&P 500 1Y: n/a
3Y total return
+159.8%
S&P 500 3Y: n/a
5Y total return
+59.8%
S&P 500 5Y: n/a
10Y total return
+175.0%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/145020?

Insider, institutional, and short-interest positioning.

Institutional ownership
+16.7%
Share of float held by funds and institutions
Insider ownership
+0.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-3.1%
Negative means the company is buying back shares.
Technical

KOSDAQ/145020 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
65.2
Neutral momentum band
Price vs 200-day MA
+7.7%
50/200-day relationship not available
Beta (5Y)
0.54
Less volatile than the market
Sharpe ratio
-0.16
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/145020

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/145020 stock rating?

kosdaq/145020 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/145020 analysis?

The full report lives at /stocks/kosdaq/145020/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/145020?

The latest report frames kosdaq/145020 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/145020 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.